Ibuprofen 200 mg liquid filled capsules Advil Liqui-Gel Minis, 160 count bottle NDC 0573-1769-89 NDC 0573-1769-95
Check against the official notice below — it lists the full affected range.
GlaxoSmithKline Consumer Healthcare is recalling Advil Liqui-Gel Minis ibuprofen 200 mg liquid filled capsules in 160-count bottles because certain lots lack required safety warning information in the Drug Facts Panel on the label. Approximately 446,628 bottles were distributed throughout the United States, including Puerto Rico. The affected lots are R53074, R53075, R53076, R53077, R53081, R53901, R53902, and R62780, with expiration dates ranging from October 2020 through June 2021.
The source record does not specify a remedy or what action affected consumers should take.
Written by software from the official notice below. Not reviewed by a lawyer.
Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.
Reason for recall: Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel. Distribution: Product was distributed throughout the United States, including Puerto Rico. Quantity: 446,628 bottles Lot/code info: Batch/Lot Numbers: R53074, exp. date 10/31/2020, item # F00573176989, 160 ct. R53075, exp. date 10/31/2020, item # F00573176989, 160 ct. R53076, exp. date 11/30/2020, item # F00573176989, 160 ct. R53077, exp. date 11/30/2020, item # F00573176989, 160 ct. R53081, exp. date 11/30/2020, item # F00573176989, 160 ct. R53901, exp. date 02/28/2021, item # F00573176989, 160 ct. R53902, exp. date 03/31/2021, item # F00573176989, 160 ct. R62780, exp. date 06/30/2021, item # F00573176989, 160 ct.
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.